TCF7L2 and pancreatic neoplasm: Inhibiting HATs in pancreatic cancer affected the activation of a certain subset of enhancers that are enriched by the Wnt-signaling transcription factor, Transcription Factor 7 Like 2 (TCF7L2) [86].